4//SEC Filing
Dreyer Scott 4
Accession 0001062993-25-005020
CIK 0001267565other
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 4:01 PM ET
Size
7.0 KB
Accession
0001062993-25-005020
Insider Transaction Report
Form 4
Dreyer Scott
EVP & Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-03-06$30.00/sh−3,295$98,854→ 144,411 total - Sale
Common Stock
2025-03-07$30.00/sh−2,348$70,446→ 142,063 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.
- [F2]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- [F3]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive.
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001746251
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 4:01 PM ET
- Size
- 7.0 KB